Algert Global’s Stereotaxis STXS Stock Holding History

Algert Global’s Portfolio STXS Stock Details STXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-16,240	Closed	-$49K	–	499
2020 Q1	$49K	Buy	+16,240	New	+$67.1K	0.02%	383

Other funds holding STXS

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Algert Global's STXS Position: Q2 2020 in Review

Algert Global sold out of Stereotaxis (STXS) in Q2 2020, closing a stake of 16,240 shares — an estimated $49K sold.

Algert Global first reported a position in STXS in Q1 2020 and held it in 1 quarter. The position peaked at $49K in Q1 2020. 74 funds tracked by Wall St. Rank hold STXS as of Q2 2020.

Algert Global reported no remaining Stereotaxis position as of Q2 2020 after selling out during the quarter.
Algert Global sold 16,240 Stereotaxis shares in Q2 2020, an estimated $49K.
Algert Global first reported a position in Stereotaxis in Q1 2020 and held it in 1 quarter.
Algert Global's Stereotaxis position peaked at $49K in Q1 2020.
74 funds tracked by Wall St. Rank held Stereotaxis as of Q2 2020.

Based on Algert Global's 13F filing for Q2 2020, filed 12 Aug 2020.